PRA Health Sciences Inc (PRAH1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
CEO:
Colin Shannon
Employees:
16,400
4130 PARKLAKE AVENUE, SUITE 400, RALEIGH, NC 27612
9197868200

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

PRA Health Sciences, Inc. operates as a contract research organization, which engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It includes data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. The company was founded in 1976 and is headquartered in Raleigh, NC.

Data derived from most recent annual or quarterly report
Market Cap 10.705 Billion Shares Outstanding64.795 Million Avg 30-day Volume 1.503 Million
P/E Ratio47.561 Dividend Yield0.0 EPS3.35
Price to Revenue3.0437 Debt to Equity0.8153 EBITDA450.022 Million
Price to Book Value6.5183 Operating Margin10.0322 Enterprise Value10.725 Billion
Current Ratio1.207 EPS Growth-0.104 Quick Ratio1.111
1 Yr BETA 1.0441 52-week High/Low 175.95 / 93.0 Profit Margin6.3995
Operating Cash Flow Growth104.5968 Altman Z-Score3.4919 Free Cash Flow to Firm 370.833 Million
View SEC Filings from PRAH1 instead.

View recent insider trading info

Funds Holding PRAH1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PRAH1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-07-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-01:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
  • 8-K: filed on 2021-06-15:
    Item 8.01: Other Events
  • 8-K: filed on 2021-06-04:
    Item 8.01: Other Events
  • 8-K: filed on 2021-06-02:
    Item 8.01: Other Events
  • 8-K: filed on 2021-05-17:
    Item 8.01: Other Events
  • 8-K: filed on 2021-04-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-04-16:
    Item 8.01: Other Events
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MOMTAZEE JAMES C

    • Director
    No longer subject to file 2021-07-01 1

    SHANNON COLIN PRESIDENT & CEO

    • Officer
    • Director
    No longer subject to file 2021-07-01 1

    GRAIS LINDA

    • Director
    No longer subject to file 2021-07-01 1

    BARBER JEFFREY T

    • Director
    No longer subject to file 2021-07-01 1

    STETTIN GLEN D.

    • Director
    No longer subject to file 2021-07-01 1

    YOUNG MATTHEW P.

    • Director
    No longer subject to file 2021-07-01 1

    GAENZLE CHRISTOPHER L EVP, CAO & GENERAL COUNSEL

    • Officer
    No longer subject to file 2021-07-01 1

    DICKINSON ALEXANDER GEORGE

    • Director
    No longer subject to file 2021-07-01 1

    BONELLO MICHAEL J. EVP & CFO

    • Officer
    No longer subject to file 2021-07-01 1

    KKR FUND HOLDINGS L.P.

    KKR FUND HOLDINGS GP LTD

    KKR & CO. INC.

    KKR MANAGEMENT LLC

    KRAVIS HENRY R

    ROBERTS GEORGE R

    KKR GROUP HOLDINGS CORP.

    0 2019-09-06 0

    KKR PRA INVESTORS L.P.

    KKR PRA INVESTORS GP II LLC

    KKR PRA INVESTORS GP LLC

    KKR NORTH AMERICA FUND XI L.P.

    KKR NORTH AMERICA XI LTD

    0 2019-09-06 0

    KKR PRA INVESTORS L.P.

    KKR PRA INVESTORS GP II LLC

    KKR PRA INVESTORS GP LLC

    KKR NORTH AMERICA FUND XI L.P.

    KKR ASSOCIATES NORTH AMERICA XI L.P.

    KKR NORTH AMERICA XI LTD

    6,695,984 2018-08-09 0

    KKR GROUP LTD

    KKR GROUP HOLDINGS L.P.

    0 2018-07-01 0

    KKR GROUP HOLDINGS CORP.

    13,195,984 2018-07-01 0

    BADDOUR LINDA EXECUTIVE VP & CFO

    • Officer
    0 2018-01-16 0

    DOCKHORN DAVID W EXECUTIVE VICE PRESIDENT & CCO

    • Officer
    0 2017-12-28 0

    KKR FUND HOLDINGS L.P.

    KKR FUND HOLDINGS GP LTD

    KKR GROUP HOLDINGS L.P.

    KKR GROUP LTD

    KKR & CO. L.P.

    KKR MANAGEMENT LLC

    KRAVIS HENRY R

    ROBERTS GEORGE R

    13,195,984 2017-08-14 0

    KKR PRA INVESTORS GP II LLC

    • 10% Owner
    39,933,657 2015-03-03 0

    LIN MAX

    • Director
    0 2014-11-12 0

    KKR PRA INVESTORS L.P.

    KKR PRA INVESTORS GP LLC

    KKR NORTH AMERICA FUND XI L.P.

    KKR ASSOCIATES NORTH AMERICA XI L.P.

    KKR NORTH AMERICA XI LTD

    • 10% Owner
    39,933,657 2014-11-12 0

    SATVAT ALI J

    • Director
    0 2014-11-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 22:15:02 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 21:45:03 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 21:15:03 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 20:45:03 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 20:15:04 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 19:45:02 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 19:15:03 UTC -0.19 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 18:45:03 UTC -0.4106 0.4706 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 18:15:03 UTC -0.4106 0.4706 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 17:45:03 UTC -0.4106 0.4706 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 17:15:03 UTC -0.4106 0.4706 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 16:45:03 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 16:15:03 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 15:45:03 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 15:15:04 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 14:45:02 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 14:15:03 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 13:45:02 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 13:15:02 UTC -0.17 0.25 2400000
    PRA HEALTH SCIENCES INC PRAH 2021-07-01 12:45:03 UTC -0.17 0.25 2300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Master Neutral Fund PRAH1 -16.0 shares, $-1623.04 2020-09-30 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund PRAH1 -3.0 shares, $-249.12 2020-03-31 N-PORT

    Elevate your investments